Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Statistics

Total Valuation

BOLT has a market cap or net worth of $15.34 million. The enterprise value is -$5.82 million.

Market Cap	15.34M
Enterprise Value	-5.82M

Important Dates

The last earnings date was Monday, March 24, 2025, after market close.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

BOLT has 38.34 million shares outstanding. The number of shares has increased by 0.98% in one year.

Current Share Class	38.34M
Shares Outstanding	38.34M
Shares Change (YoY)	+0.98%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	3.98%
Owned by Institutions (%)	24.37%
Float	27.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.11
Forward PS	14.52
PB Ratio	0.28
P/TBV Ratio	0.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.20, with a Debt / Equity ratio of 0.44.

Current Ratio	3.20
Quick Ratio	3.04
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -74.28% and return on invested capital (ROIC) is -39.60%.

Return on Equity (ROE)	-74.28%
Return on Assets (ROA)	-32.88%
Return on Invested Capital (ROIC)	-39.60%
Return on Capital Employed (ROCE)	-81.45%
Revenue Per Employee	$76,900
Profits Per Employee	-$631,180
Employee Count	100
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.16% in the last 52 weeks. The beta is 0.94, so BOLT's price volatility has been similar to the market average.

Beta (5Y)	0.94
52-Week Price Change	-65.16%
50-Day Moving Average	0.47
200-Day Moving Average	0.60
Relative Strength Index (RSI)	43.87
Average Volume (20 Days)	137,269

Short Selling Information

The latest short interest is 24,333, so 0.06% of the outstanding shares have been sold short.

Short Interest	24,333
Short Previous Month	38,888
Short % of Shares Out	0.06%
Short % of Float	0.09%
Short Ratio (days to cover)	0.24

Income Statement

In the last 12 months, BOLT had revenue of $7.69 million and -$63.12 million in losses. Loss per share was -$1.65.

Revenue	7.69M
Gross Profit	-49.78M
Operating Income	-68.24M
Pretax Income	-63.03M
Net Income	-63.12M
EBITDA	-66.46M
EBIT	-68.24M
Loss Per Share	-$1.65

Balance Sheet

The company has $47.32 million in cash and $25.21 million in debt, giving a net cash position of $22.11 million or $0.58 per share.

Cash & Cash Equivalents	47.32M
Total Debt	25.21M
Net Cash	22.11M
Net Cash Per Share	$0.58
Equity (Book Value)	57.20M
Book Value Per Share	1.49
Working Capital	34.96M

Cash Flow

In the last 12 months, operating cash flow was -$61.29 million and capital expenditures -$41,000, giving a free cash flow of -$61.33 million.

Operating Cash Flow	-61.29M
Capital Expenditures	-41,000
Free Cash Flow	-61.33M
FCF Per Share	-$1.60

Margins

Gross Margin	n/a
Operating Margin	-887.33%
Pretax Margin	-820.78%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BOLT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.98%
Shareholder Yield	n/a
Earnings Yield	-387.36%
FCF Yield	-376.39%

Analyst Forecast

The average price target for BOLT is $1.13, which is 182.50% higher than the current price. The consensus rating is "Hold".

Price Target	$1.13
Price Target Difference	182.50%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	27.09%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BOLT has an Altman Z-Score of -7.31 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.31
Piotroski F-Score	3